Clinical outcomes in combination versus mono antibiotic therapy in ICU admitted patients with a suspected infection - A substudy of the DIANA study
- 19 December 2023
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 80, 154501
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet
This publication has 24 references indexed in Scilit:
- Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and ProtocolsPLOS Medicine, 2014
- Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) auditThe Lancet Respiratory Medicine, 2014
- The Value of Statistical Analysis Plans in Observational ResearchJAMA, 2012
- Combination Therapy for Treatment of Infections with Gram-Negative BacteriaClinical Microbiology Reviews, 2012
- Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe SepsisJAMA, 2012
- Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*Critical Care Medicine, 2010
- A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression studyCritical Care Medicine, 2010
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJAMA, 2009
- Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia*Critical Care Medicine, 2008
- Comparison of Levofloxacin and Cefotaxime Combined With Ofloxacin for ICU Patients With Community-Acquired Pneumonia Who Do Not Require VasopressorsChest, 2005